[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-336243-105":59,"doc-detail-336243-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","role-of-cd44-and-cd24-expression-on-2-years-disease-free-survival-in-patients-with-advanced-epithelial-ovarian-carcinoma","Role of CD44 and CD24 Expression on 2-years Disease Free Survival in Patients with Advanced Epithelial Ovarian Carcinoma","","Ovarian cancer remains a leading cause of gynecologic cancer mortality, with recurrence frequently occurring despite optimal surgery and chemotherapy. Cancer stem cells expressing CD44 and CD24 are proposed contributors to relapse. A cohort retrospective survival analysis was conducted on advanced epithelial ovarian cancer patients treated with optimal debulking surgery and six chemotherapy cycles. CD44 and CD24 expression in tumor tissue was assessed by H-score, with cutoffs derived from ROC curves, and disease-free survival was evaluated using survival curves. High CD44 and CD24 expression significantly shortened 2-year disease-free survival.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/role-of-cd44-and-cd24-expression-on-2-years-disease-free-survival-in-patients-with-advanced-epithelial-ovarian-carcinoma/336243/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/role-of-cd44-and-cd24-expression-on-2-years-disease-free-survival-in-patients-with-advanced-epithelial-ovarian-carcinoma/336243.png","ImageObject",300,407,{"name":92,"@type":93},"Aurora","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the main objective of the study?","Question",{"text":112,"@type":113},"To examine the relationship between CD24 and CD44 expression levels in tumor tissue and two-year disease-free survival in epithelial ovarian carcinoma patients.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were CD44 and CD24 expression levels measured?",{"text":117,"@type":113},"CD44 and CD24 expression were assessed using immunohistochemical examination and quantified with the H-score method, with expression cutoffs determined using ROC curve analysis.",{"name":119,"@type":110,"acceptedAnswer":120},"What was the overall conclusion about CD44 and CD24 expression?",{"text":121,"@type":113},"Higher CD44 and CD24 expression was associated with shorter disease-free survival in patients with advanced ovarian cancer.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},336243,1790806457,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":34,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},4810365810221,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","RESEARCH ARTICLE  \nEditorial Process: Submission:08/23/2023 Acceptance:02/11/2024  \nRole of CD44 and CD24 Expression on 2-years Disease Free Survival in Patients with Advanced Epithelial Ovarian Carcinoma  \nYuri Feharsal1 *, Andr Andrijono2, Chamim Shobari Singoprawiro1, Lisnawati Lisnawati3, Trevino Aristarkus Pakasi4, AndiDarma Putra2, Fitriyadi Kusuma2, Tricia Dewi Anggraeni 2 , Erlina Erlina 5 , Sarwanti Sarwanti 5 , Tha’atam Mardhiyah2  \nAbstract  \nObjective: Ovarian cancer is one of the most common cancers with a high mortality rate worldwide. Despite optimal surgical therapy and chemotherapy, recurrence is still common. Cancer stem cells expressing CD44 and CD24 are thought to be contributing factors in recurrence. Methods: A cohort retrospective study with survival analysis was carried out on advanced ovarian cancer patients who underwent optimal debulking surgery followed by 6 cycles of chemotherapy at Cipto Mangunkusumo General Hospital and Fatmawati General Hospital from January 2019 to March 2023. Immunohistochemical examination was performed on tumor tissue with CD44 and CD24 expression were assessed using the H-Score method then determined the cut off-point expression level using the ROC curve. Furthermore, the relationship between these expression levels with the disease-free survival was assessed using the survival curve. Results: There were 48 subjects who were included in the study. There were high expression levels of CD44 in 47.9% and CD24 in 50% of cases. High CD44 expression had mean and median survival of 13.2 ± 1.8 and 11 months (HR 5.05, 95% CI 1.84-13.85) . High CD24 expression had mean and median survival of 13.5 ± 2.4 and 7 months (HR 7.73, 95% CI 2.58 – 23.15) . The combination of the two high expressions had mean and median survival of 10.44 ± 1.88 and 7 months. Conclusion: High expression of CD44 and CD24 will shorten the disease-free survival of patients with advanced ovarian cancer.  \nKeywords: Ovarian cancer-cancer stem cells-CD44-CD24-disease-free survival  \nAsian Pac J Cancer Prev, 25 (2), 513-519  \nIntroduction  \nOvarian carcinoma is the third most common gynecological carcinoma worldwide after cervical and uterine carcinoma [1] . In 2020, the World Health Organization (WHO) reported 313,959 cases of ovarian carcinoma in women globally through the Global Burden of Cancer (GLOBOCAN) data register, with a mortality rate of 207,252 [2]. According to the data from the Indonesian Society of Gynecologic Oncology (INASGO) for the period 2019–2021, 1,600 cases of ovarian carcinoma were reported in Indonesia, with serous cystadenocarcinoma and mucinous cystadenocarcinoma dominating the cases [3] . Given the poor diagnosis at the advanced stage and delay in diagnosis, ovarian carcinoma remains the second  \nleading cause of death in gynecological carcinoma. The five-year survival rate of ovarian carcinoma in women worldwide is approximately 30%–40%[4] .  \nDespite cytoreductive surgery and chemotherapy, recurrence is common. Ovarian cancer recurrence rates range from 10% in stage Ito 20% in stage II, with advanced stages (III and IV) accounting for up to 62%–85% of cases [5] . One of the prognostic factors for recurrence that is currently being studied is the presence of cancer stem cell (CSC) factors. Recent studies have revealed the emerging role of CSC expression in contributing to poor clinical manifestations; therefore, the presence of CSC surface markers, such as CD24 and CD44, can be used to predict prognosis in ovarian carcinoma [6]. High CD24 expression corresponds with grading, prognosis, and aggressiveness  \n1Department of Obstetrics and Gynecology, Fatmawati Central General Hospital, Jakarta, Indonesia. 2Department of Obstetricsand Gynecology, Dr. Cipto Mangunkusumo National Central General Hospital, Jakarta, Indonesia. 3Department of Pathological Anatomy, Dr. CiptoMangunkusumo National Central General Hospital, Jakarta, Indonesia. 4Department of Community Medicine, Faculty of Medicine, Uni","cbCaiazavVG1zkwH","https://ap.wps.com/l/cbCaiazavVG1zkwH","pdf",1429612,"English","# Abstract\n# Introduction\n# Materials and Methods\n## Study Design and Data Collection\n## Subjects","[{\"question\":\"What was the main objective of the study?\",\"answer\":\"To examine the relationship between CD24 and CD44 expression levels in tumor tissue and two-year disease-free survival in epithelial ovarian carcinoma patients.\"},{\"question\":\"How were CD44 and CD24 expression levels measured?\",\"answer\":\"CD44 and CD24 expression were assessed using immunohistochemical examination and quantified with the H-score method, with expression cutoffs determined using ROC curve analysis.\"},{\"question\":\"What was the overall conclusion about CD44 and CD24 expression?\",\"answer\":\"Higher CD44 and CD24 expression was associated with shorter disease-free survival in patients with advanced ovarian cancer.\"}]","Role of CD44 and CD24 Expression on 2-years Disease Free Survival in Patients with Advanced Epithelial Ovarian Carcinoma | PDF",1790014233,18,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d5da575659ff75271b223caa15c256fe.webp",983,1390,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9bffe2829ce8b33b094bb6ab7caf15f1.webp",982,1388,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d68085805c841c5b8990d812b7fab356.webp",981,1387,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/89500d4b34a8f19027a170cbf8469feb.webp",980,1385]